Trump administration wanted to "flood" states with hydroxychloroquine, Vanity Fair reports
The anti-malaria drug hydroxychloroquine gained widespread attention after President Trump started touting it as a possible "game changer" in the fight against COVID-19. Internal documents obtained by Vanity Fair show how Trump administration officials sought the nationwide distribution of tens of millions of doses, even as evidence mounted of both serious side effects and low efficacy against the novel coronavirus. Investigative journalist Katherine Eban joins CBSN to discuss her findings.